Table 1.
Baseline main clinical characteristics of all participants, breast cancer survivors (BCSs) and controls.
Table 2.
Changes in psychological features in patients with breast cancer and controls at baseline and after 6 months of treatment with aromatase inhibitors.
Fig 1.
Clinical psychological features and comparison at baseline (Left column of each signature) and after 6 months (Right column of each signature).
Bars = mean values; Error bars = 95% CI for means; * = p<0.05 vs baseline; # = p<0.05 vs controls; BCSs = Breast Cancer Survivors; BDI-II = Beck Depression Inventory II edition; HAM-A = Hamilton Anxiety Rating Scale; PCS = Physical Component Summary; MCS = Mental Component Summary.
Table 3.
Correlation analysis at baseline between the studied variables of all participants.